aap Implantate AG (AAQ1) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.052x

Based on the latest financial reports, aap Implantate AG (AAQ1) has a cash flow conversion efficiency ratio of -0.052x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-659.50K ≈ $-771.02K USD) by net assets (€12.63 Million ≈ $14.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see aap Implantate AG market capitalisation for the company's overall valuation and market capitalisation.

aap Implantate AG - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how aap Implantate AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

aap Implantate AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of aap Implantate AG ranked by their cash flow conversion efficiency. See aap Implantate AG cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Safari World PLC BK:SAFARI	0.111x
Intergama TA:INTR	0.054x
Apollo Power Ltd TA:APLP	-0.074x
GeneBioTech Co. Ltd KQ:086060	-0.004x
IL&FS Investment Managers Limited NSE:IVC	-0.037x
Metal Energy Corp V:MERG	0.042x
SONOKONG Co. Ltd KQ:066910	0.007x
Inmofam 99 SOCIMI SA MC:YINM	-0.021x

Annual Cash Flow Conversion Efficiency for aap Implantate AG (2016–2024)

The table below shows the annual cash flow conversion efficiency of aap Implantate AG from 2016 to 2024. View current stock price of aap Implantate AG for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€10.46 Million ≈ $12.23 Million	€-1.12 Million ≈ $-1.31 Million	-0.107x	+70.14%
2023-12-31	€8.10 Million ≈ $9.47 Million	€-2.92 Million ≈ $-3.41 Million	-0.360x	-143.82%
2022-12-31	€12.83 Million ≈ $15.00 Million	€-1.89 Million ≈ $-2.21 Million	-0.148x	+23.67%
2021-12-31	€12.78 Million ≈ $14.94 Million	€-2.47 Million ≈ $-2.89 Million	-0.193x	+45.86%
2020-12-31	€10.29 Million ≈ $12.03 Million	€-3.67 Million ≈ $-4.30 Million	-0.357x	-16.83%
2019-12-31	€18.87 Million ≈ $22.06 Million	€-5.77 Million ≈ $-6.74 Million	-0.306x	-80.31%
2018-12-31	€34.92 Million ≈ $40.82 Million	€-5.92 Million ≈ $-6.92 Million	-0.170x	-32.90%
2017-12-31	€42.56 Million ≈ $49.76 Million	€-5.43 Million ≈ $-6.35 Million	-0.128x	+3.01%
2016-12-31	€54.78 Million ≈ $64.04 Million	€-7.20 Million ≈ $-8.42 Million	-0.131x	--

About aap Implantate AG

F:AAQ1 Germany Medical Devices

Market Cap

$26.84 Million

€22.96 Million EUR

Market Cap Rank

#24227 Global

#2092 in Germany

Share Price

€1.56

Change (1 day)

-4.29%

52-Week Range

€1.27 - €2.22

All Time High

€21.70